SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-035105
Filing Date
2020-11-05
Accepted
2020-11-04 18:48:59
Documents
2
Period of Report
2020-11-01
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea129188-8k_emmauslife.htm 8-K 22914
2 LETTER DATED NOVEMBER 4, 2020 FROM SQUAR MILNER, LLP TO THE SECURITIES AND EXCHA ea129188ex16-1_emmauslife.htm EX-16.1 2587
  Complete submission text file 0001213900-20-035105.txt   26914
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35527 | Film No.: 201288087
SIC: 2834 Pharmaceutical Preparations